130 likes | 1.02k Views
ENTEROBACTER AMNIGENUS : A NEW CAUSE FOR NEONATAL SEPSIS. Yousef K. Abu-Osba*; Amer Ammari; Khalil Salameh; Mamoun Shalabi; Kamal El-Haj *Neonatal Medicine Services, Jordan Hospital, Amman, Jordan Neonatal Medicine Services, and Microbiology Section, Hamad General Hospital, Doha, Qatar.
E N D
ENTEROBACTER AMNIGENUS :A NEW CAUSE FOR NEONATAL SEPSIS Yousef K. Abu-Osba*; Amer Ammari; Khalil Salameh; Mamoun Shalabi; Kamal El-Haj *Neonatal Medicine Services, Jordan Hospital, Amman, Jordan Neonatal Medicine Services, and Microbiology Section, Hamad General Hospital, Doha, Qatar
ENTEROBACTERAMNIGENUS NEONATAL SEPSISClinical Characteristics Case SEX APGAR B.W. AT Onset of sepsis 1 5 (g) Weight Age d.1 m 2 6 880 1120 47 2 f 7 9 1000 1020 14 3 f 7 8 1100 940 9 4 m 7 9 1020 1020 9 5 f 7 8 1040 1000 9
ENTEROBACTER AMNIGENUS NEONATAL SEPSISClinical Presentation NO T. H.R A. Dis. Acidosis Glucose UVC UAC P.Line C mmol/L Pre / During 1 39 194 + - 4.2 +/- +/- + 2 36.7 180 + - 4.6 -/- +/- + 3 37 158 - + 13.4 +/- +/+ + 4 35 150 - - 9.7 +/+ -/- + 5 36.7 175 - - 9.8 +/+ +/+ +
ENTEROBACTER AMNIGENUS NEONATAL SEPSISHematological Presentation NO WBC BAND RATIO Platelets Blood Tx (1.1-6.0) (500) (.12) (1000) • 9200 22/19 1.2 36 YES • 21000 16/61 .26 64 YES* • 28300 16/72 .22 33 YES* • 7600 0/46 0 26 YES • 12200 0/86 0 26 YES* Ref.: Revised Reference Ranges For Circulating Neutrophils in Very-Low Birth-Weight Neonates. (PEDIATRICS Vol. 94 No. 1 July 1994)
ENTEROBACTER AMNIGENUS NEONATAL SEPSISImmunological Presentation NO IMMUNOGLOBULINS ESR CRP IgG IgA IgM mm> 6mg/L 1 660 16 62 25 + 2 208 7 22 27 + 3 - - - 9 + 4 465 10 12 2 + 5 419 33 31 8 +
ENTEROBACTER AMNIGENUS NEONATAL SEPSISSepsis Episodes During Hospitalization Case BEFORE DURING AFTER (Age d.) (Age d.) (Age d.) 1 CANDIDA (40) E. FECALIS E. AGGLOMERANS (76) 2 K. PNEUMONIAE (11) -- SERRATIA MERSESCANS (30) S. EPIDERMIDIS (60) 3 -- S. EPIDERMIDIS -- 4 -- -- S. MERSESCANS (26) S. EPIDERMIDIS (75) 5 -- - E. FECALIS (49) MICROCOCCUS (79)
ENTEROBACTER AMNIGENUS NEONATAL SEPSISAntibiotics Treatment Case Treatment* Culture -ve Previous During Sepsis Days Post Treatment 1 AMPH,AMP AMK (12D), CPX (1D) 8 D 2 - AMK (14D), CPX (14D) 5 D 3 - IMP (14D), AMK (19D) 13 D CPX (10D) 4 AMP, CPX AMK (15D), CPX (15D) 3 D 5 - IMP (15D), AMK (17D) 11D CPX (10D) * AMPH: Amphotericin, AMP: Ampicillin, CPX: Cephotaxime, IMP: Imipenem.
ENTEROBACTER AMNIGENUS NEONATAL SEPSISENTEROBACTER AMNIGENUS BIOGROUP 2 (MIC) SENSITIVERESISTANT AMPICILLIN (>32/16) CEFOTITAN (>32) AMIKACIN SULBACTAM (>32/16) CEFTRIAXONE (>64) CPROFLOXACIN<.25) AMPICILLIN (>32) CEFTAZIDIME (>32) COTRIMOXAZOLE AUGMENTIN >32/16) CEFTIZOXIME (>32) GENTAMICIN AZTREONAM (>32) CEFUROXIME IMIPENEM(<.5) AZLOCILLIN (>64) CEPHALOTHIN NETILMICIN (4) CEFAMANDOLE (>32) CARBENICILLIN (128) CHLORAMPHENICOL (8) CEFONICID (>16) MEZLOCILLIN (>128) CEFOPERAZONE (>32) TICARCILLIN (>128) CEFOTAXIME (>64) TICARCILLIN (>128) PIPERACILLIN
ENTEROBACTER AMNIGENUS NEONATAL SEPSISENTEROBACTER AMNIGENUS IDENTIFICATION REACTIONS AFTER 2 DAYS OF INCUBATION BIOGROUP 1 BIOGROUP 2 Lysine decarboxylase (LDC) - - Arginine dihydrolase (ADH) - v Ornithine decarboxylase (ODC) v + Growth in KCN + + Fermentation of: Sucrose + - D-sorbitol - + Raffinose + - Yellow Pigment - -
ENTEROBACTER AMNIGENUS :A NEW CAUSE FOR NEONATAL SEPSIS SUMMARY - 1 • We report for the first time in our area sepsis secondary to ENTEROBACTER AMNIGENUS in 5 premature infants, who had positive blood cultures and suffered from clinical signs and symptoms of infection. • Enterobacter amnigenus was isolated from both the aerobic and anaerobic bottles on several occasions. Identification of the source of infection was difficult to ascertain.
ENTEROBACTER AMNIGENUS :A NEW CAUSE FOR NEONATAL SEPSIS SUMMARY - 2 • Aggressive treatment with antibiotics and supportive measures were required. • All isolates were resistant to third generation cephalosporins and sensitive to amikacin and gentamicin. • All patients survived.
ENTEROBACTER AMNIGENUS :A NEW CAUSE FOR NEONATAL SEPSIS Conclusions • Enterobacter amnigenus can cause sepsis in susceptible or immuno-compromised infants like very premature infants, which required aggressive therapy. • Amikacin, gentamicin and imipenem are the drug of choice. • Imipenem may be used if aminoglycosides are contraindicated.